Clinical Trial Update: BRITEPath, Component 3 of iCHART (Integrated Care to Help At-Risk Teens) [NA]

View source ↗

Summary

A completed trial update for BRITEPath, part of iCHART, studying depression and suicidal ideation in at-risk teens; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidal Ideation

Snippet

Sponsor: University of Pittsburgh | Conditions: Depression, Suicidal Ideation | NA | Status: COMPLETED | Results posted: 2022-08-08